SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Church who wrote (993)7/17/1997 12:57:00 PM
From: JOHN W.   of 6136
 
For those that have or will miss the mtg, you can call 1-800-998-2460 for a replay starting at 5 pm EST. Amy has not presented her brief yet, but some interesting observations thus far:
1) the one side effect associated with nelf which is very controllable with over the counter medication is often experienced with Crixivan combo therapies much more severely.

2) It is common for complete cessation of all drugs due to formation of kidney stones. One should not just stop Crixivan due to kidney stones, but come off all the drugs to prevent a partial, sub-optimal pressure on the virus inviting resistance.

3) Dr. Patick will present this afternoon.

Regards, John.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News